Yield10 Bioscience Profit Margin

The latest profit margin for YTEN is -1568.15% as of June 2024. That compares with -5518.22% in the prior-year period — up 71.6% year over year. That is below the Consumer Discretionary sector average of 10.26%. Investors often review this figure alongside Yield10 Bioscience's historical trend and sector peers before judging valuation or financial health.

Over the past year, YTEN's profit margin moved from -5518.22% to -1568.15% — a 71.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Yield10 Bioscience's valuation or profitability profile.

Against Consumer Discretionary companies, YTEN currently prints -1568.15% for profit margin, while the sector average sits near 10.26%. That is roughly 15379.6% below the sector mean. Large gaps often invite a closer look at Yield10 Bioscience's growth, margins, and balance sheet.

Profit Margin shows how effectively Yield10 Bioscience converts resources into returns. At -1568.15%, YTEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -5518.22% in the prior-year period — up 71.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting YTEN's profit margin (-1568.15%), review year-over-year change from -5518.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.